Neuroscience in the midst of COVID-19

The ABC understands the importance of keeping education and advocacy at the forefront during this unprecedented time. We have assembled a variety of resources below to benefit patients with all types of brain disorders, their families, caregivers, and brain-related professionals. These resources include COVID-19 sites of trusted ABC members and affiliates, breaking research emerging on neurological and psychological effects of the SARS-CoV-2 virus, federal bills and summaries affecting the patient advocacy community, along with COVID-19 research and funding opportunities.


COVID-19 and THE BRAIN

Anxiety and Depression Are Rising...


COVID-19 Linked to Blood Clots and Strokes


COVID-19 Testing and Treatment Issues

 

How COVID-19 May Impact Mental Health

 

Stress and Coping

 

The Neurology and Neuropsychiatry of COVID-19

 

The Path Forward: Academic Neurology Responds to COVID-19

  

HILL UPDATES

H.R. 226 (Signed into law on April 24, 2020)   

 

H.R. 748 (Signed into law on March 27, 2020)

 

H.R. 6201 (Signed into law on March 18, 2020) 

 

H.R. 6074 (Signed into law March 6, 2020)

COVID-19 RESOURCES

     

 

    

 

 

 

 

 

 

     

 

    

 

 

 

 


COVID-19 Research & Funding Opportunities

The Social, Behavioral, and Economic (SBE) sciences are pleased to announce this new Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) from the National Science Foundation (NSF). They invite submission of proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge. Please refer to the FAQs for Proposers and Awardees to address questions associated with proposal submission. 


National Institute of Health issues Notice of Intent to Publish (NOITP) four Funding Opportunity Announcements as part of the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative, a $500 million initiative to reduce COVID-19 associated morbidity and mortality disparities for vulnerable and underserved populations that are disproportionately affected by COVID-19. The FOAs, in which NIDA will be participating, will include three Notices of Special Interest to solicit community-engaged research to understand COVID-19 disparities and increase access to and effectiveness of diagnostic testing interventions among underserved and vulnerable populations, and to understand the social, ethical, and behavioral implications of testing in these populations. An RFA to support a Coordination and Data Collection Center (CDCC) will also be announced. The FOAs are expected to be published in early June. Applications will be accepted through August 2020 for FY20 funding.

 


American Brain Coalition

P.O. Box 1549 | Maple Grove, MN 55311 | Phone: (763) 557-2913